All In Biotech

Free tool

FAERS Monitor: Ixempra Kit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022065 or its brand name (Ixempra Kit, Ixabepilone). Reports on generic versions are filed under their own applications.

Reports

1,051

Serious

857

82% of reports

Hospitalization

421

Death reported

242

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death106
  • vomiting94
  • nausea93
  • anaemia91
  • fatigue89
  • diarrhoea76
  • malignant neoplasm progression70
  • neutropenia70
  • white blood cell count decreased69
  • neutrophil count decreased67
  • dyspnoea60
  • dehydration57
  • neuropathy peripheral52
  • febrile neutropenia49
  • disease progression45

Reports by year received

View as table
YearReports
200412
200521
200627
200723
200895
200979
201085
201157
2012139
201384
201481
201570
2016117
201752
201830
201910
20207
202115
202223
20234
20249
20259
20262

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,108 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
neutrophil count decreasedSignal6732.926.12,044
febrile neutropeniaSignal4914.811.3618
malignant neoplasm progressionSignal7013.710.9814
white blood cell count decreasedSignal6912.710.1739
neuropathy peripheralSignal5210.98.4462
neutropeniaSignal7010.38.2583
anaemiaSignal919.67.8694
dehydrationSignal578.66.6375
disease progressionSignal457.65.7253
vomitingSignal944.03.3213
deathSignal1062.52.194
diarrhoeaSignal762.41.960
nauseaSignal932.41.974
fatigueSignal892.31.966
dyspnoeaSignal602.11.735

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.